Literature DB >> 7306866

Effect or premedicants, intravenous anaesthetic agents an local anaesthetics on phagocytosis in vitro.

G C Moudgil.   

Abstract

Mesh：

Substances：

Year:  1981        PMID： 7306866     DOI： 10.1007/bf03007159

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN： 0008-2856


× No keyword cloud information.
  13 in total

1.  Anesthesia and immunology.

Authors:  P G Duncan; B F Cullen
Journal:  Anesthesiology       Date:  1976-11       Impact factor: 7.892

Review 2.  Host defense mechanisms against infection.

Authors:  J W Alexander
Journal:  Surg Clin North Am       Date:  1972-12       Impact factor: 2.741

3.  The effect of halothane and nitrous oxide on phagocytosis and human leukocyte metabolism.

Authors:  B F Cullen
Journal:  Anesth Analg       Date:  1974 Jul-Aug       Impact factor: 5.108

4.  Effect of halothane anesthesia on experimental Salmonella peritonitis in mice.

Authors:  D L Bruce
Journal:  J Surg Res       Date:  1967-04       Impact factor: 2.192

5.  [Phagocytic activity of the blood and in peritoneal exudate in general anesthesia with fluothane].

Authors:  E Kościolek
Journal:  Ann Acad Med Stetin       Date:  1967

Review 6.  Anaesthesia and immunocompetence.

Authors:  G C Moudgil; A G Wade
Journal:  Br J Anaesth       Date:  1976-01       Impact factor: 9.166

7.  Plasma lidocaine concentrations after caudal, lumbar epidural, axillary block, and intravenous regional anesthesia.

Authors:  R I Mazze; R W Dunbar
Journal:  Anesthesiology       Date:  1966 Sep-Oct       Impact factor: 7.892

8.  Pharmacokinetics of thiopentone: effects of enflurane and nitrous oxide anaesthesia and surgery.

Authors:  M M Ghoneim; M J Van Hamme
Journal:  Br J Anaesth       Date:  1978-12       Impact factor: 9.166

9.  Pharmacokinetics of methohexitone following intravenous infusion in humans.

Authors:  D D Breimer
Journal:  Br J Anaesth       Date:  1976-07       Impact factor: 9.166

10.  Inhibition, by anaesthetic agents, of human leucocyte locomotion towards chemical attractants.

Authors:  G C Moudgil; R B Allan; R J Russell; P C Wilkinson
Journal:  Br J Anaesth       Date:  1977-02       Impact factor: 9.166
View more
  9 in total

Review 1.  Comparative tolerability of sedative agents in head-injured adults.

Authors:  Susan C Urwin; David K Menon
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

2.  Effects of Propofol and Midazolam on the Inflammation of Lungs after Intravenous Endotoxin Administration in Rats.

Authors:  Mine Gursac Celik; Ayten Saracoglu; Tolga Saracoglu; Husnu Kursad; Aysenur Dostbil; Mehmet Aksoy; Ali Ahiskalioglu; Ilker Ince
Journal:  Eurasian J Med       Date:  2015-06

3.  Postpartum stroke successfully treated with high-dose pentobarbitone therapy: a case report.

Authors:  N G Caseby
Journal:  Can Anaesth Soc J       Date:  1983-01

4.  Some effects of lignocaine on cultured mouse peritoneal macrophages.

Authors:  G W Cambridge; J F Parsons; J V Friend; P A Jones
Journal:  Agents Actions       Date:  1985-09

Review 5.  Pharmacodynamics and pharmacokinetics of thiopental.

Authors:  H Russo; F Bressolle
Journal:  Clin Pharmacokinet       Date:  1998-08       Impact factor: 6.447

6.  Spinal anaesthesia but not general anaesthesia enhances neutrophil biocidal activity in hip arthroplasty patients.

Authors:  R Erskine; P K Janicki; G Neil; M F James
Journal:  Can J Anaesth       Date:  1994-07       Impact factor: 5.063

Review 7.  The use of sedative agents in critically ill patients.

Authors:  A M Burns; M P Shelly; G R Park
Journal:  Drugs       Date:  1992-04       Impact factor: 9.546

8.  The effects of intravenous anaesthetic agents on human neutrophil chemiluminescence.

Authors:  I W White; A W Gelb; H R Wexler; C R Stiller; P A Keown
Journal:  Can Anaesth Soc J       Date:  1983-09

9.  Neutrophils from patients undergoing hip surgery exhibit enhanced movement under spinal anaesthesia compared with general anaesthesia.

Authors:  R Erskine; P K Janicki; P Ellis; M F James
Journal:  Can J Anaesth       Date:  1992-11       Impact factor: 5.063
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.